Who Paid My Doc
Tarceva
Drug BioOncology
NDC 50242-064-01
General payments
$8,004
Research payments
$13,903,569
Through program year 2022, $8,004 in general payments and $13,903,569 in research payments were reported against Tarceva (BioOncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $301 | 14 |
| 2022 | Research | $1,570,456 | 144 |
| 2021 | Research | $3,531,651 | 357 |
| 2020 | General | $113 | 1 |
| 2020 | Research | $4,384,358 | 538 |
| 2019 | General | $7,590 | 12 |
| 2019 | Research | $4,417,104 | 640 |
Breakdown
The top 5 of 11 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
27 general · 1,679 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.